TETRACOQ injection suspension medication leaflet

J07CA02 • diphtheria + tetanus + pertussis + polio vaccine inactivated • Antiinfectives for systemic use | Bacterial and viral vaccines, combined

The diphtheria, tetanus, pertussis, inactivated polio (DTP-IPV) vaccine is used to prevent diphtheria, tetanus, whooping cough (pertussis), and poliomyelitis, four serious infectious diseases caused by bacteria and viruses. The vaccine contains diphtheria and tetanus toxoids, inactivated or purified components of Bordetella pertussis, and inactivated poliovirus, which stimulate the immune system to produce specific antibodies against these pathogens.

The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. Booster doses are required at regular intervals to maintain immunity.

Common side effects include pain at the injection site, mild fever, fatigue, and irritability. In rare cases, severe allergic reactions may occur.

The DTP-IPV vaccine is an essential measure for protecting public health, helping to reduce the incidence and severity of these infectious diseases and prevent the severe complications associated with them.